.png){kind=icon}
Return
Are data from different gene expression microarray platforms comparable?
.png){kind=icon}
PRE
AI
DOI：10.1016/j.ygeno.2004.01.004.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Many commercial and custom-made microarray formats are routinely used for large-scale gene expression Surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synthesized oligonucleotide arrays (Affymetrix HG-U95v2), commercial cDNA microarrays (Agilent Human 1 cDNA), and custom-made cDNA microarrays from a sequence-validated 13K cDNA library. Gene expression data from the commercial platforms showed good correlations across the experiments (r = 0.78-0.86), whereas the correlations between the custom-made and either of the two commercial platforms were lower (r = 0.62-0.76). Discrepant findings were due to Clone errors on the custom-made microarrays, old annotations, or unknown causes. Even within platform, there can be several ways to analyze data that may influence the correlation between platforms. Our results indicate that combining data from different microarray platforms is not straightforward. Variability of the data represents a challenge for developing future diagnostic applications of microarrays. (C) 2004 Elsevier Inc. All rights reserved.
Keywords:
cDNA microarrays
oligonucleotide rnicroarrays
quality control
breast cancer
Journal
IF:
3
Papers:
7.2K
Citations:
1.2W
Organization
No organization information available
Cited Papers
ShareSaveShareSaveShareSaveShareSave
Evaluation of drilling performances of nanocomposites reinforced with graphene and graphene oxide
PREAI
ShareSaveMetabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study.png)
Neuroscience
NeuroscienceIF0
PREAI
ShareSaveShareSaveShareSave
View more